Global Imatinib Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
- GLO2765736
- 120 Pages
- September 2018
- Pharmaceuticals
Scope of the Report:
This report focuses on the Imatinib Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of imatinib drug are expected to drive the imatinib drug market. Furthermore, rise in healthcare expenditure and increase in awareness of cancer by government and private organizations are anticipated to boost the market growth.
The worldwide market for Imatinib Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Novartis
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Cipla Inc.
Apotex Inc.
Mylan Pharms Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tablets
Capsules
Market Segment by Applications, can be divided into
Chronic myelogenous leukemia
Gastrointestinal stromal tumors
Others
There are 15 Chapters to deeply display the global Imatinib Drug market.
Chapter 1, to describe Imatinib Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Imatinib Drug, with sales, revenue, and price of Imatinib Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Imatinib Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Imatinib Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Imatinib Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 Market Overview
1.1 Imatinib Drug Introduction
1.2 Market Analysis by Type
1.2.1 Tablets
1.2.2 Capsules
1.3 Market Analysis by Applications
1.3.1 Chronic myelogenous leukemia
1.3.2 Gastrointestinal stromal tumors
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Imatinib Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Glenmark Pharmaceuticals Ltd.
2.2.1 Business Overview
2.2.2 Imatinib Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sun Pharmaceuticals
2.3.1 Business Overview
2.3.2 Imatinib Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sun Pharmaceuticals Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Actavis Generics
2.4.1 Business Overview
2.4.2 Imatinib Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Actavis Generics Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Dr. Reddy's Laboratories
2.5.1 Business Overview
2.5.2 Imatinib Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Dr. Reddy's Laboratories Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Teva Pharmaceutical Industries Ltd.
2.6.1 Business Overview
2.6.2 Imatinib Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanofi S.A.
2.7.1 Business Overview
2.7.2 Imatinib Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi S.A. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cipla Inc.
2.8.1 Business Overview
2.8.2 Imatinib Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cipla Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Apotex Inc.
2.9.1 Business Overview
2.9.2 Imatinib Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Apotex Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Mylan Pharms Inc.
2.10.1 Business Overview
2.10.2 Imatinib Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Mylan Pharms Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Imatinib Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Imatinib Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Imatinib Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Imatinib Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Imatinib Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Imatinib Drug Market Analysis by Regions
4.1 Global Imatinib Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Imatinib Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Imatinib Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Imatinib Drug Sales and Growth Rate (2013-2018)
4.3 Europe Imatinib Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Imatinib Drug Sales and Growth Rate (2013-2018)
4.5 South America Imatinib Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Imatinib Drug Sales and Growth Rate (2013-2018)
5 North America Imatinib Drug by Countries
5.1 North America Imatinib Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Imatinib Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Imatinib Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Imatinib Drug Sales and Growth Rate (2013-2018)
5.3 Canada Imatinib Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Imatinib Drug Sales and Growth Rate (2013-2018)
6 Europe Imatinib Drug by Countries
6.1 Europe Imatinib Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Imatinib Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Imatinib Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Imatinib Drug Sales and Growth Rate (2013-2018)
6.3 UK Imatinib Drug Sales and Growth Rate (2013-2018)
6.4 France Imatinib Drug Sales and Growth Rate (2013-2018)
6.5 Russia Imatinib Drug Sales and Growth Rate (2013-2018)
6.6 Italy Imatinib Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Imatinib Drug by Countries
7.1 Asia-Pacific Imatinib Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Imatinib Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Imatinib Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Imatinib Drug Sales and Growth Rate (2013-2018)
7.3 Japan Imatinib Drug Sales and Growth Rate (2013-2018)
7.4 Korea Imatinib Drug Sales and Growth Rate (2013-2018)
7.5 India Imatinib Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Imatinib Drug Sales and Growth Rate (2013-2018)
8 South America Imatinib Drug by Countries
8.1 South America Imatinib Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Imatinib Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Imatinib Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Imatinib Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Imatinib Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Imatinib Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Imatinib Drug by Countries
9.1 Middle East and Africa Imatinib Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Imatinib Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Imatinib Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Imatinib Drug Sales and Growth Rate (2013-2018)
9.3 UAE Imatinib Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Imatinib Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Imatinib Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Imatinib Drug Sales and Growth Rate (2013-2018)
10 Global Imatinib Drug Market Segment by Type
10.1 Global Imatinib Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Imatinib Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Imatinib Drug Revenue and Market Share by Type (2013-2018)
10.2 Tablets Sales Growth and Price
10.2.1 Global Tablets Sales Growth (2013-2018)
10.2.2 Global Tablets Price (2013-2018)
10.3 Capsules Sales Growth and Price
10.3.1 Global Capsules Sales Growth (2013-2018)
10.3.2 Global Capsules Price (2013-2018)
11 Global Imatinib Drug Market Segment by Application
11.1 Global Imatinib Drug Sales Market Share by Application (2013-2018)
11.2 Chronic myelogenous leukemia Sales Growth (2013-2018)
11.3 Gastrointestinal stromal tumors Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Imatinib Drug Market Forecast (2018-2023)
12.1 Global Imatinib Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Imatinib Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Imatinib Drug Market Forecast (2018-2023)
12.2.2 Europe Imatinib Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Imatinib Drug Market Forecast (2018-2023)
12.2.4 South America Imatinib Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Imatinib Drug Market Forecast (2018-2023)
12.3 Imatinib Drug Market Forecast by Type (2018-2023)
12.3.1 Global Imatinib Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Imatinib Drug Market Share Forecast by Type (2018-2023)
12.4 Imatinib Drug Market Forecast by Application (2018-2023)
12.4.1 Global Imatinib Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Imatinib Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Imatinib Drug Picture
Table Product Specifications of Imatinib Drug
Figure Global Sales Market Share of Imatinib Drug by Types in 2017
Table Imatinib Drug Types for Major Manufacturers
Figure Tablets Picture
Figure Capsules Picture
Figure Imatinib Drug Sales Market Share by Applications in 2017
Figure Chronic myelogenous leukemia Picture
Figure Gastrointestinal stromal tumors Picture
Figure Others Picture
Figure United States Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Imatinib Drug Revenue (Value) and Growth Rate (2013-2023)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Imatinib Drug Type and Applications
Table Novartis Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Glenmark Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table Glenmark Pharmaceuticals Ltd. Imatinib Drug Type and Applications
Table Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceuticals Imatinib Drug Type and Applications
Table Sun Pharmaceuticals Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Actavis Generics Basic Information, Manufacturing Base and Competitors
Table Actavis Generics Imatinib Drug Type and Applications
Table Actavis Generics Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table Dr. Reddy's Laboratories Imatinib Drug Type and Applications
Table Dr. Reddy's Laboratories Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Ltd. Imatinib Drug Type and Applications
Table Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table Sanofi S.A. Imatinib Drug Type and Applications
Table Sanofi S.A. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cipla Inc. Basic Information, Manufacturing Base and Competitors
Table Cipla Inc. Imatinib Drug Type and Applications
Table Cipla Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Apotex Inc. Basic Information, Manufacturing Base and Competitors
Table Apotex Inc. Imatinib Drug Type and Applications
Table Apotex Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Pharms Inc. Basic Information, Manufacturing Base and Competitors
Table Mylan Pharms Inc. Imatinib Drug Type and Applications
Table Mylan Pharms Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Imatinib Drug Sales by Manufacturer (2016-2017)
Figure Global Imatinib Drug Sales Market Share by Manufacturer in 2016
Figure Global Imatinib Drug Sales Market Share by Manufacturer in 2017
Table Global Imatinib Drug Revenue by Manufacturer (2016-2017)
Figure Global Imatinib Drug Revenue Market Share by Manufacturer in 2016
Figure Global Imatinib Drug Revenue Market Share by Manufacturer in 2017
Figure Top 3 Imatinib Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Imatinib Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Global Imatinib Drug Revenue and Growth Rate (2013-2018)
Table Global Imatinib Drug Sales by Regions (2013-2018)
Table Global Imatinib Drug Sales Market Share by Regions (2013-2018)
Table Global Imatinib Drug Revenue by Regions (2013-2018)
Figure Global Imatinib Drug Revenue Market Share by Regions in 2013
Figure Global Imatinib Drug Revenue Market Share by Regions in 2017
Figure North America Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Europe Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Imatinib Drug Sales and Growth Rate (2013-2018)
Figure South America Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Imatinib Drug Sales and Growth Rate (2013-2018)
Figure North America Imatinib Drug Revenue and Growth Rate (2013-2018)
Table North America Imatinib Drug Sales by Countries (2013-2018)
Table North America Imatinib Drug Sales Market Share by Countries (2013-2018)
Figure North America Imatinib Drug Sales Market Share by Countries in 2013
Figure North America Imatinib Drug Sales Market Share by Countries in 2017
Table North America Imatinib Drug Revenue by Countries (2013-2018)
Table North America Imatinib Drug Revenue Market Share by Countries (2013-2018)
Figure North America Imatinib Drug Revenue Market Share by Countries in 2013
Figure North America Imatinib Drug Revenue Market Share by Countries in 2017
Figure United States Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Canada Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Mexico Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Europe Imatinib Drug Revenue and Growth Rate (2013-2018)
Table Europe Imatinib Drug Sales by Countries (2013-2018)
Table Europe Imatinib Drug Sales Market Share by Countries (2013-2018)
Table Europe Imatinib Drug Revenue by Countries (2013-2018)
Figure Europe Imatinib Drug Revenue Market Share by Countries in 2016
Figure Europe Imatinib Drug Revenue Market Share by Countries in 2017
Figure Germany Imatinib Drug Sales and Growth Rate (2013-2018)
Figure UK Imatinib Drug Sales and Growth Rate (2013-2018)
Figure France Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Russia Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Italy Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Imatinib Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Imatinib Drug Sales by Countries (2013-2018)
Table Asia-Pacific Imatinib Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Imatinib Drug Sales Market Share by Countries 2017
Table Asia-Pacific Imatinib Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Imatinib Drug Revenue Market Share by Countries 2017
Figure China Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Japan Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Korea Imatinib Drug Sales and Growth Rate (2013-2018)
Figure India Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Imatinib Drug Sales and Growth Rate (2013-2018)
Figure South America Imatinib Drug Revenue and Growth Rate (2013-2018)
Table South America Imatinib Drug Sales by Countries (2013-2018)
Table South America Imatinib Drug Sales Market Share by Countries (2013-2018)
Figure South America Imatinib Drug Sales Market Share by Countries in 2017
Table South America Imatinib Drug Revenue by Countries (2013-2018)
Table South America Imatinib Drug Revenue Market Share by Countries (2013-2018)
Figure South America Imatinib Drug Revenue Market Share by Countries in 2017
Figure Brazil Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Argentina Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Colombia Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Imatinib Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Imatinib Drug Sales by Countries (2013-2018)
Table Middle East and Africa Imatinib Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Imatinib Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Imatinib Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Imatinib Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Imatinib Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Imatinib Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Imatinib Drug Sales and Growth Rate (2013-2018)
Figure UAE Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Egypt Imatinib Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Imatinib Drug Sales and Growth Rate (2013-2018)
Figure South Africa Imatinib Drug Sales and Growth Rate (2013-2018)
Table Global Imatinib Drug Sales by Type (2013-2018)
Table Global Imatinib Drug Sales Share by Type (2013-2018)
Table Global Imatinib Drug Revenue by Type (2013-2018)
Table Global Imatinib Drug Revenue Share by Type (2013-2018)
Figure Global Tablets Sales Growth (2013-2018)
Figure Global Tablets Price (2013-2018)
Figure Global Capsules Sales Growth (2013-2018)
Figure Global Capsules Price (2013-2018)
Table Global Imatinib Drug Sales by Application (2013-2018)
Table Global Imatinib Drug Sales Share by Application (2013-2018)
Figure Global Gastrointestinal stromal tumors Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Imatinib Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Imatinib Drug Sales Forecast by Regions (2018-2023)
Table Global Imatinib Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Imatinib Drug Market Forecast (2018-2023)
Figure Europe Sales Imatinib Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Imatinib Drug Market Forecast (2018-2023)
Figure South America Sales Imatinib Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Imatinib Drug Market Forecast (2018-2023)
Table Global Imatinib Drug Sales Forecast by Type (2018-2023)
Table Global Imatinib Drug Market Share Forecast by Type (2018-2023)
Table Global Imatinib Drug Sales Forecast by Application (2018-2023)
Table Global Imatinib Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
